Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide + UDCA in Primary Biliary Cholangitis
NCT00746486Phase 3Terminated
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Feb 2009
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of EPI-EE in primary biliary cholangitis (PBC), sponsored by Dr. Falk Pharma GmbH. Started Feb 2009; status: terminated.
02
Drugs
EPI-EE
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT00746486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746486.